http://rdf.ncbi.nlm.nih.gov/pubchem/patent/PE-20091671-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_07b71571160c289fbf5fc680dfea513f
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-12
filingDate 2009-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e827bd20311f302ebb287940fd7bef27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_60c6a84ffea87770faf99bc6738ce620
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f3b15339a22282db75df2cb8fd2334e8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c1b0debe2785d49def6bd464cecc4e3a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e957ea8eaf45663ad69e3d86286beac3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_798f496e739c23a9c60464c0094681d1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_677906031a11181d0c3c77f0a07630bd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c4211ba2840a7a05bbb75dd56fe7ef8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd34f089743fd6c003623d73f697e968
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c5f124cf8f755d5215175ceaeaa2454
publicationDate 2009-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber PE-20091671-A1
titleOfInvention ANTIVIRAL COMPOUNDS, COMPOSITIONS AND METHODS TO USE THEM
abstract REFERRED TO A COMPOUND OF FORMULA (I), WHERE B IS AN AROMATIC RING OF 6 MEMBERS, OPTIONALLY WITH 1-3 HETEROTATOMES OF N; AND WHERE THE B RING CAN BE FUSED TO ARILO, HETEROARILO, HETEROCICLO, AMONG OTHERS; L1 IS C3-C6 CYCLOALKYLENE, C1-C5 ALKYLENE; L2 IS A BOND, C3-C6 CYCLOALKYLENE, C1-C5 ALKYLENE; ONE OF V O T IS N AND THE OTHER IS CR3; Q IS N, CR3; R1 IS ARYL, HETEROARILO, HETEROCICLILO, AMONG OTHERS; R2 IS H, HALO, AMINO, AMONG OTHERS; R3 IS H, HALO, AMINO, ACILAMINO, AMONG OTHERS; R4 IS ARYL, HETEROARYL, CYCLOALKYL, AMONG OTHERS. THE SELECTED COMPOUNDS ARE: 2- (2-FLUORO-PHENYL) -5- (4-TRIFLUOROMETOXY-BENZYL) -5H-IMIDAZINE [4,5-D] PYRIDAZINE; 5- [6- (2,4-BIS-TRIFLUOROMETHYL-PHENYL] -PYRIDAZIN-3-ILMEthyl] -2- (2,3-DIFLUORO-PHENYL) -5H-IMIDAZO [4,5-D] PYRIDAZINE; 2- (2,3-DIFLUORO-PHENYL) -5- [6- (4-ETOXY-PHENYL) -PYRIDAZIN-3-ILMETYL] -5H-IMIDAZINE [4,5-D] PYRIDAZINE; AMONG OTHERS. ALSO REFERS TO A METHOD OF PREPARATION AND A PHARMACEUTICAL COMPOSITION SAID COMPOUND HAS ACTIVITY ON VIRUSES OF THE FLAVIVIRIDAE FAMILY AND IS USEFUL IN THE TREATMENT OF HEPATITIS B
priorityDate 2008-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9259
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419522963

Total number of triples: 26.